These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 24980839)

  • 21. What's next after 50 years of psychiatric drug development: an FDA perspective.
    Laughren TP
    J Clin Psychiatry; 2010 Sep; 71(9):1196-204. PubMed ID: 20923624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stent thrombosis in the era of drug eluting stents.
    Kawaguchi R; Angiolillo DJ; Futamatsu H; Suzuki N; Bass TA; Costa MA
    Minerva Cardioangiol; 2007 Apr; 55(2):199-211. PubMed ID: 17342038
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Late and very late stent thrombosis in patients with second-generation drug-eluting stents.
    Huang KN; Grandi SM; Filion KB; Eisenberg MJ
    Can J Cardiol; 2013 Nov; 29(11):1488-94. PubMed ID: 23830291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Triple antiplatelet therapy reduces ischemic events after drug-eluting stent implantation: Drug-Eluting stenting followed by Cilostazol treatment REduces Adverse Serious cardiac Events (DECREASE registry).
    Lee SW; Park SW; Yun SC; Kim YH; Park DW; Kim WJ; Lee JY; Lee CW; Hong MK; Kim JJ; Park SJ
    Am Heart J; 2010 Feb; 159(2):284-291.e1. PubMed ID: 20152228
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A critical appraisal of the safety and efficacy of drug-eluting stents.
    Maluenda G; Lemesle G; Waksman R
    Clin Pharmacol Ther; 2009 May; 85(5):474-80. PubMed ID: 19279567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence of thrombosis after implantation of drug-eluting stents in patients with coronary artery disease.
    Chen JL; Yang YJ; Gao LJ; Huang JH; Qin XW; Qiao SB; Xu B; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Li JJ; Gao RL
    Chin Med J (Engl); 2008 Nov; 121(21):2144-7. PubMed ID: 19080174
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stent restenosis and thrombosis: etiology, treatment, and outcomes.
    van Buuren F; Dahm JB; Horskotte D
    Minerva Med; 2012 Dec; 103(6):503-11. PubMed ID: 23229369
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical outcome of percutaneous treatment of in-stent restenosis with drug-eluting stents: results from the first phase of the prospective multicentre German DES.DE registry.
    Abdel-Wahab M; Nienaber CA; Mostafa AE; Sabin G; Tebbe U; Hochadel M; Senges J; Akin I; Kuck KH; Hamm C; Richardt G;
    EuroIntervention; 2011 Jun; 7(2):201-8. PubMed ID: 21646062
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical evidence on polymer-based sirolimus and paclitaxel eluting stents.
    Iijima R; Mehilli J; Schömig A; Kastrati A
    Minerva Cardioangiol; 2006 Oct; 54(5):539-55. PubMed ID: 17019392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies.
    Moreno R; Fernández C; Hernández R; Alfonso F; Angiolillo DJ; Sabaté M; Escaned J; Bañuelos C; Fernández-Ortiz A; Macaya C
    J Am Coll Cardiol; 2005 Mar; 45(6):954-9. PubMed ID: 15766835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Real polymer-free sirolimus- and probucol-eluting versus biodegradable polymer sirolimus-eluting stents for obstructive coronary artery disease: DKPLUS-Wave 1, a multicenter, randomized, prospective trial.
    Chen SL; Ye F; Zhang JJ; Zou JJ; Qian XS; Li F; Yang S; Ge Z; Shan SJ; Li XB; Xu T; Kan J; Lin L; Han YL
    Cardiovasc Ther; 2013 Aug; 31(4):193-200. PubMed ID: 22954234
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical outcomes following drug-eluting versus bare metal stent implantation for lesion subsets excluded from pivotal clinical trials: findings from the GHOST Study (Guthrie Health System Off-Label StenT Study).
    Harjai KJ; Orshaw P; Shenoy C; Acharji S; Sporn D; Aboufares A; Stapleton D
    J Interv Cardiol; 2008 Aug; 21(4):315-24. PubMed ID: 18754967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vascular remodeling after coronary stent implantation.
    Vorpahl M; Virmani R; Ladich E; Finn AV
    Minerva Cardioangiol; 2009 Oct; 57(5):621-8. PubMed ID: 19838152
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence and very long- term outcomes of stent thrombosis after bare-metal or drug-eluting stent implantation: a retrospective analysis.
    Pullara A; Longo G; Gonella A; D'Ascenzo F; Biondi Zoccai G; Moretti C; Sciuto F; Omedè PL; Bollati M; Gaita F; Sheiban I
    Minerva Cardioangiol; 2013 Feb; 61(1):1-9. PubMed ID: 23381375
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stent choice in primary percutaneous coronary intervention: drug-eluting stents or bare metal stents?
    Valgimigli M; Airoldi F; Zimarino M
    J Cardiovasc Med (Hagerstown); 2009 Oct; 10 Suppl 1():S17-26. PubMed ID: 19851216
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term patient benefit with biodegradable polymer biolimus eluting stent.
    Corti R
    Minerva Cardioangiol; 2012 Dec; 60(6):629-36. PubMed ID: 23147439
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence and clinical impact of fracture of drug-eluting stents widely used in current clinical practice: comparison with initial platform of sirolimus-eluting stent.
    Park MW; Chang K; Her SH; Lee JM; Choi YS; Kim DB; Kim PJ; Cho JS; Choi MS; Baek JY; Park CS; Yoon SG; Chung WS; Seung KB
    J Cardiol; 2012 Sep; 60(3):215-21. PubMed ID: 22890068
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term effects of drug-eluting stents versus bare metal stents on patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: outcomes of 3-year clinical follow-up.
    Wang CH; Fang Q; Zhang SY; Shen ZJ; Fan ZJ; Jin XF; Zeng Y; Liu ZY; Xie HZ; Yang M
    Chin Med J (Engl); 2012 Aug; 125(16):2803-6. PubMed ID: 22932070
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current status of drug-eluting stents.
    Räber L; Windecker S
    Cardiovasc Ther; 2011 Jun; 29(3):176-89. PubMed ID: 20370793
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of drug-eluting stents in ST-segment elevation myocardial infarction: a meta-analysis of randomized trials.
    De Luca G; Stone GW; Suryapranata H; Laarman GJ; Menichelli M; Kaiser C; Valgimigli M; Di Lorenzo E; Dirksen MT; Spaulding C; Pittl U; Violini R; Percoco G; Marino P
    Int J Cardiol; 2009 Apr; 133(2):213-22. PubMed ID: 18394731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.